Evidence map›Paper›PMID 34218200›Full record

ArticleRedox biology2021

The E3 ubiquitin ligase TRIM31 is involved in cerebral ischemic injury by promoting degradation of TIGAR.

Shenglan Zeng, Ze Zhao, Shengnan Zheng, Mengting Wu, Xiaomeng Song, Yiquan Li, Yi Zheng, Bingyu Liu, Lin Chen, Chengjiang Gao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Shenglan ZengDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Ze ZhaoDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Shengnan ZhengDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Mengting WuDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Xiaomeng SongDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Yiquan LiDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Yi ZhengKey Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Bingyu LiuKey Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Lin ChenDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China.
Chengjiang GaoKey Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China. Electronic address: cgao@sdu.edu.cn.
Huiqing LiuDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, PR China. Electronic address: liuhuiqing@sdu.edu.cn.
Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tripartite motif (TRIM) 31 has been implicated in diverse biological and pathological conditions. However, whether TRIM31 plays a role in ischemic stroke progression is not clarified. Here we demonstrated that TRIM31 was significantly downregulated in the ischemic brain and the deficiency of TRIM31 alleviated brain injury induced by middle cerebral artery occlusion by reducing reactive oxygen species production and maintaining mitochondrial homeostasis. Mechanistically, we found that TRIM31 is an E3 ubiquitin ligase for TP53-induced glycolysis and apoptosis regulator (TIGAR), which confers protection against brain ischemia by increasing the pentose phosphate pathway flux and preserving mitochondria function. TRIM31 interacted with TIGAR and promoted the polyubiquitination of TIGAR, consequently facilitated its degradation in a proteasome-dependent pathway. Furthermore, TIGAR knockdown effectively abolished the protective effect of TRIM31 deficiency after cerebral ischemia. In conclusion, we identified that TRIM31 was a novel E3 ubiquitin ligase for TIGAR, played a critical role in regulating its protein level, and subsequently involved in the ischemic brain injury, suggesting TRIM31 as a potential therapeutic target for ischemic stroke.

Indexed as

Brain InjuriesAnimalsApoptosisApoptosis Regulatory ProteinsGlycolysisMaleMiceMice, Inbred C57BLPhosphoric Monoester HydrolasesTripartite Motif ProteinsUbiquitinationUbiquitin-Protein LigasesApoptosis Regulatory ProteinsPhosphoric Monoester HydrolasesTIGAR protein, mouseTRIM31 protein, mouseTripartite Motif ProteinsUbiquitin-Protein LigasesIschemic strokeMitochondriaReactive oxygen speciesTIGARTRIM31

Identifiers

PMID34218200
PMCPMC8260875
OpenAlexW3173330190

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.